Systemic adverse reactions to glaucoma medications.
Fraunfelder
F T
FT
Department of Ophthalmology, Oregon Health Sciences University, Portland 97201.
Meyer
S M
SM
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001337:Autonomic Agents / Q000009:adverse effects*; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002493:Central Nervous System Diseases / Q000139:chemically induced; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D010277:Parasympathomimetics / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D001337:Autonomic Agents; D002257:Carbonic Anhydrase Inhibitors; D010277:Parasympathomimetics; D013566:Sympathomimetics